Your browser doesn't support javascript.
loading
Fertility Improvement of Hysteroscopy with Chromopertubation in the Management of Infertile Women with Hysterosalpingography Evidence of Abnormal Tubal Patency: A Prospective Comparative Study.
Shen, Hailan; Lu, Ye; Su, Ruide; Wang, Kai; Wang, Wenrong; An, Jian.
Afiliação
  • Shen H; Department of Family Planning, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  • Lu Y; Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  • Su R; Department of Family Planning, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  • Wang K; Department of Family Planning, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  • Wang W; Department of Family Planning, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  • An J; Department of Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
Int J Womens Health ; 14: 1613-1619, 2022.
Article em En | MEDLINE | ID: mdl-36411745
ABSTRACT

Purpose:

To investigate the clinical value of hysteroscopy with chromopertubation (HSC) in infertile patients with hysterosalpingography (HSG) evidence of abnormal tubal patency.

Methods:

The study consisted of 296 patients. HSG was performed as a preliminary test for the evaluation of fallopian tube status. Patients who desired to conceive naturally were treated with HSC in the next month or followed-up without additional treatment. The primary outcome was natural clinical pregnancy within 12 months after the procedure.

Results:

In total, the number of clinical pregnancies was estimated to be 70 of 143 (48.95%) clinical pregnancies with management by HSC and 65 of 153 (42.48%) pregnancies with management comprising follow-up without additional treatment, and this was not significantly different (Log rank test, P = 0.516). Subgroup analysis showed that among women with bilateral abnormalities by HSG, patients receiving management with HSC tended to have a higher probability of pregnancy throughout the follow-up period than women without HSG (Log rank test, P = 0.005). No corresponding significant difference was found for women with a unilateral abnormality (P = 0.674).

Conclusion:

HSC shows potential fertility improvement value for infertile patients with tubal factors. HSC may be complementary to HSG and could be incorporated as a modality of the fertility work-up.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Womens Health Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Womens Health Ano de publicação: 2022 Tipo de documento: Article